MF
Mani Foroohar Leerink Partners Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Moderna
MRNA
$9.66B
| $24.83 | $15 |
40%
downside
| Underperform |
22 Aug ‘25
17 days ago |
|
2
Sarepta Therapeutics
SRPT
$1.84B
| $17.60 | $10 |
43%
downside
| Market Perform |
21 Jul ‘25
1 month ago |
|
3
Rocket Pharmaceuticals
RCKT
$352M
| $3.26 | $8 |
145%
upside
| Market Perform |
28 May ‘25
3 months ago |
|
4
Lexeo Therapeutics
LXEO
$284M
| $5.25 | $18 |
243%
upside
| Outperform |
24 Mar ‘25
5 months ago |
|
5
Recursion Pharmaceuticals
RXRX
$2.02B
| $4.62 | $6 |
30%
upside
| Market Perform |
28 Feb ‘25
6 months ago |
|
6
4D Molecular Therapeutics
FDMT
$326M
| $6.97 | $27 |
287%
upside
| Outperform |
13 Jan ‘25
7 months ago |
|
7
Neurogene
NGNE
$278M
| $19.45 | $72 |
270%
upside
| Outperform |
12 Nov ‘24
10 months ago |
|
8
CAMP4 Therapeutics Corporation Common Stock
CAMP
$33.3M
| $1.65 | $17 |
930%
upside
| Outperform |
5 Nov ‘24
10 months ago |
|
9
Mirum Pharmaceuticals
MIRM
$3.89B
| $77.39 | $49 |
37%
downside
| Outperform |
17 Oct ‘24
10 months ago |
|
10
BridgeBio Pharma
BBIO
$10.4B
| $54.29 | $46 |
15%
downside
| Outperform |
17 Oct ‘24
10 months ago |
|
11
Wave Life Sciences
WVE
$1.21B
| $7.58 | $22 |
190%
upside
| Outperform |
16 Oct ‘24
10 months ago |
|
12
Ionis Pharmaceuticals
IONS
$9.72B
| $61 | $62 |
2%
upside
| Outperform |
24 Jul ‘24
1 year ago |
|
13
Benitec Biopharma
BNTC
$363M
| $13.84 | $13 |
6%
downside
| Outperform |
22 Jul ‘24
1 year ago |
|
14
Schrodinger
SDGR
$1.43B
| $19.44 | $29 |
49%
upside
| Outperform |
2 Jul ‘24
1 year ago |
|
|
15
Sarepta Therapeutics
SRPT
$1.84B
| $17.60 | $230 |
1,207%
upside
| Outperform |
24 Jun ‘24
1 year ago |
|
16
CureVac
CVAC
$1.2B
| $5.35 | $4 |
25%
downside
| Market Perform |
25 Apr ‘24
1 year ago |
|
17
enGene Holdings
ENGN
$278M
| $5.43 | $31 |
471%
upside
| Outperform |
20 Feb ‘24
1 year ago |
|
|
KLRS
18
Kalaris Therapeutics, Inc. Common Stock
KLRS
$86.8M
| $4.64 | $23 |
396%
upside
| Market Perform |
22 Dec ‘23
1 year ago |
|
19
Tenaya Therapeutics
TNYA
$228M
| $1.40 | $7 |
400%
upside
| Outperform |
30 Nov ‘23
1 year ago |
|
|
20
CureVac
CVAC
$1.2B
| $5.35 | $13 |
143%
upside
| Outperform |
8 Jun ‘23
2 years ago |
|
21
Arrowhead Research
ARWR
$3.76B
| $27.17 | $40 |
47%
upside
| Market Perform |
12 May ‘23
2 years ago |
|
|
KLRS
22
Kalaris Therapeutics, Inc. Common Stock
KLRS
$86.8M
| $4.64 | $437 |
9,318%
upside
| Outperform |
26 Apr ‘23
2 years ago |
|
|
23
BridgeBio Pharma
BBIO
$10.4B
| $54.29 | $27 |
50%
downside
| Outperform |
13 Apr ‘23
2 years ago |
|
|
24
4D Molecular Therapeutics
FDMT
$326M
| $6.97 | $13 |
87%
upside
| Market Perform |
13 Apr ‘23
2 years ago |
|
|
25
Arrowhead Research
ARWR
$3.76B
| $27.17 | $35 |
29%
upside
| Outperform |
12 Apr ‘23
2 years ago |
|